IL-6–mediated inhibition of CD122 allows T FH cells to receive TCR signaling without initiating an inhibitory TCR/IL-2 loop (see the related Focus by Zhou and Yu )..
No takes yet. Share an insight, caveat, or question.
Papillion et al. (2019) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: